In The News Posted April 23, 2019 Share Posted April 23, 2019 HUMMELSTOWN, Pa., April 23, 2019 /PRNewswire/ -- Prescient Medicine Holdings Inc. announced today it has acquired AutoGenomics Inc., a privately-held U.S. molecular diagnostics company, which has developed and commercialized the INFINITI® platform – a 510(k) exempt, automated,... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.